Heart surgery can be traumatic for patients. Having to continuously monitor your status without a doctor when you are back home can be even scarier. Imagine being able to do that with a simple sticker applied to your body.
The use of thalidomide by pregnant women resulted in horrific birth defects in more than 10,000 children around the world. Now, Purdue University researchers have developed a new chemical process to find better drug ‘fits’ for patients.
Purdue University researchers are testing whether a simple light-emitting diode array that is safe to use on human skin can be used to inactivate methicillin-resistant Staphylococcus aureus, or MRSA, one of six ‘high priority’ pathogens that the World Health Organization has identified as an imminent threat to public health. Here the light shines above a 96-well plate in a bio-safety hood.
Hope for an alarmingly low number of gray whales in the western Pacific Ocean might rest with their cousins to the east, according to a Purdue University study of the animals’ genetic resources.
A new tool developed by Purdue researchers would automatically identify and expose ways to make app features more energy-efficient, saving battery life.
When and how the first humans reached North America is a complicated puzzle. Scientists believe these people arrived in Alaska after crossing the Bering Strait, only to be stopped by the enormous Laurentide and Cordilleran ice sheets. The migrants would eventually make their way down to the Americas via one of two paths: the western coast of Canada or an opening between the two ice sheets.
A team of Purdue University researchers, led by Sabre Kais, a professor of chemistry, has received a grant for $2.5 million from the U.S. Department of Energy to develop new quantum technologies and systems.
A Purdue University researcher has combined his wealth of experience in wireless and wireline communication with his longstanding passion for medical sciences, to develop an invention with the potential to improve health care, neuroscience and human-computer interaction.
A new nonaddictive drug compound discovered by Purdue University researchers could lead to the treatment of chronic pain without the need to rely on opioids, just as a bipartisan package of bills moves through the U.S. House and Senate to battle the nation’s opioid epidemic.
A compound developed by a research team led by Val Watts, professor of medicinal chemistry and molecular pharmacology and associate dean for research in Purdue’s College of Pharmacy, shows unparalleled selectivity in inhibiting the adenylyl cyclase 1 (AC1), making it a potential target for treating pain and reducing the dependency on opioids for pain management.
Purdue University researchers are studying ways to make prostate cancer, ranked as the second most common and second most fatal cancer among men by the American Cancer Society, less lethal by making it less aggressive.